Back to Search
Start Over
Degradation of pro-insulin-receptor proteins by proteasomes.
- Source :
-
Archives of medical research [Arch Med Res] 2004 Jan-Feb; Vol. 35 (1), pp. 18-23. - Publication Year :
- 2004
-
Abstract
- Background: Type-2 diabetes is characterized by hyperinsulinemia, peripheral insulin resistance, and diminished tyrosine phosphorylation activity. It has been recently shown that proteasomes are implicated in the degradation of the insulin receptor substrate-1 (IRS-1) but not in that of the insulin receptor (IR). However, it is unknown whether proteasomes are involved in pro-IR degradation.<br />Methods: We used CHO-IR and the 3T3-L1 cells treated with insulin at different concentrations and compared the proteasome activity of IRS-1, IR, and pro-IR degradation either in presence or in absence of lactacystin.<br />Results: A total of 100 nM of insulin allowed degradation of IRS-1 after 6 h of incubation. At 1,000 nM of insulin, pro-IR degradation began at 1 h of incubation, similar to IRS-1 degradation. Surprisingly, at a higher concentration (10 microM) of insulin, a drastic decrease of proteins was observed from the first minute of incubation. This activity was blocked by lactacystin, a specific proteasome inhibitor.<br />Conclusions: According to these results, we propose that pro-IR is degraded by proteasomes.
- Subjects :
- 3T3 Cells
Animals
CHO Cells
Cricetinae
Cysteine Proteinase Inhibitors metabolism
Diabetes Mellitus, Type 2 metabolism
Humans
Insulin metabolism
Insulin Receptor Substrate Proteins
Mice
Multienzyme Complexes antagonists & inhibitors
Phosphoproteins metabolism
Proteasome Endopeptidase Complex
Cysteine Endopeptidases metabolism
Multienzyme Complexes metabolism
Protein Precursors metabolism
Receptor, Insulin metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0188-4409
- Volume :
- 35
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Archives of medical research
- Publication Type :
- Academic Journal
- Accession number :
- 15036795
- Full Text :
- https://doi.org/10.1016/j.arcmed.2003.08.008